{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T19:08:01Z","timestamp":1782760081390,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Oslo University Hospital"},{"DOI":"10.13039\/501100005366","name":"University of Oslo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"crossref","award":["2014090"],"award-info":[{"award-number":["2014090"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.bbadis.2016.01.017","type":"journal-article","created":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T07:01:15Z","timestamp":1453791675000},"page":"670-678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["EPAS1\/HIF-2 alpha-mediated downregulation of tissue factor pathway inhibitor leads to a pro-thrombotic potential in endothelial cells"],"prefix":"10.1016","volume":"1862","author":[{"given":"Benedicte","family":"Stavik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Espada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue Yan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sverre","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Mowinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente","family":"Halvorsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grethe","family":"Skretting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5556-8099","authenticated-orcid":false,"given":"Per Morten","family":"Sandset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2016.01.017_bb0005","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm0603-653","article-title":"Angiogenesis in health and disease","volume":"9","author":"Carmeliet","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0010","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1073\/pnas.86.8.2839","article-title":"Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque","volume":"86","author":"Wilcox","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0015","first-page":"1087","article-title":"Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis","volume":"134","author":"Drake","year":"1989","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0020","first-page":"291","article-title":"Tissue factor pathway inhibitor expression in atherosclerosis","volume":"77","author":"Drew","year":"1997","journal-title":"Lab. Investig."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0025","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1161\/01.ATV.20.5.1362","article-title":"Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels","volume":"20","author":"Crawley","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0030","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/01.CIR.94.6.1226","article-title":"Identification of active tissue factor in human coronary atheroma","volume":"94","author":"Marmur","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2016.01.017_bb0035","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1055\/s-0038-1650283","article-title":"Tissue factor induces migration of cultured aortic smooth muscle cells","volume":"75","author":"Sato","year":"1996","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0040","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0049-3848(02)00345-6","article-title":"Protease-activated receptor 2 (PAR2) mediates vascular smooth muscle cell migration induced by tissue factor\/factor VIIa complex","volume":"107","author":"Marutsuka","year":"2002","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0045","doi-asserted-by":"crossref","first-page":"8663","DOI":"10.1073\/pnas.96.15.8663","article-title":"Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor","volume":"96","author":"Abe","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0050","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1586\/erc.11.40","article-title":"The missing link between atherosclerosis, inflammation and thrombosis: is it tissue factor?","volume":"9","author":"Cimmino","year":"2011","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0055","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1056\/NEJMra1011670","article-title":"The hemostatic system as a modulator of atherosclerosis","volume":"364","author":"Borissoff","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0060","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.molmed.2008.08.001","article-title":"Factor Xa: at the crossroads between coagulation and signaling in physiology and disease","volume":"14","author":"Borensztajn","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0065","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/cvr\/cvp066","article-title":"Is thrombin a key player in the \u2018coagulation\u2013atherogenesis\u2019 maze?","volume":"82","author":"Borissoff","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0070","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1161\/01.ATV.0000246797.05781.ad","article-title":"Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein E-deficient mice","volume":"26","author":"Bea","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0075","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2007-04-086611","article-title":"Accelerated atherogenesis and neointima formation in heparin cofactor II-deficient mice","volume":"110","author":"Vicente","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2016.01.017_bb0080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000006999","article-title":"Changes of plasma tissue factor and tissue factor pathway inhibitor antigen levels and induction of tissue factor expression on the monocytes in coronary artery disease","volume":"93","author":"Kim","year":"2000","journal-title":"Cardiology"},{"key":"10.1016\/j.bbadis.2016.01.017_bb0085","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1055\/s-0037-1614932","article-title":"Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients","volume":"79","author":"Falciani","year":"1998","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0090","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.blre.2013.03.001","article-title":"The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosis","volume":"27","author":"Winckers","year":"2013","journal-title":"Blood Rev."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0095","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/CIRCRESAHA.109.195016","article-title":"Vascular-directed tissue factor pathway inhibitor overexpression regulates plasma cholesterol and reduces atherosclerotic plaque development","volume":"105","author":"Pan","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pcad.2008.09.001","article-title":"Atherosclerotic plaque stability\u2014what determines the fate of a plaque?","volume":"51","author":"Halvorsen","year":"2008","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0105","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jacc.2007.12.025","article-title":"Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis","volume":"51","author":"Sluimer","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0110","first-page":"164","article-title":"Immunohistochemical study of intimal microvessels in coronary atherosclerosis","volume":"143","author":"Zhang","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0115","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.jacc.2008.12.056","article-title":"Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions: relevance of compromised structural integrity for intraplaque microvascular leakage","volume":"53","author":"Sluimer","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0120","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.jacc.2007.01.089","article-title":"Plaque neovascularization and antiangiogenic therapy for atherosclerosis","volume":"49","author":"Doyle","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0125","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/RES.0b013e31823bdb84","article-title":"Tension in the plaque: hypoxia modulates metabolism in atheroma","volume":"109","author":"Libby","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0130","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1161\/01.CIR.0000146787.16297.E8","article-title":"Arterial neovascularization and inflammation in vulnerable patients: early and late signs of symptomatic atherosclerosis","volume":"110","author":"Fleiner","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2016.01.017_bb0135","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/jama.290.14.1906","article-title":"Obstructive sleep apnea: implications for cardiac and vascular disease","volume":"290","author":"Shamsuzzaman","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.bbadis.2016.01.017_bb0140","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-2141.2005.05617.x","article-title":"Air travel and thrombosis","volume":"130","author":"Chee","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0145","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1538-7836.2010.03819.x","article-title":"Explanations for coagulation activation after air travel","volume":"8","author":"Schreijer","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0150","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1378\/chest.09-2764","article-title":"The effects of hypoxia on markers of coagulation and systemic inflammation in patients with COPD","volume":"138","author":"Sabit","year":"2010","journal-title":"CHEST J."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0155","first-page":"369","article-title":"Short-term isocapnic hypoxia and coagulation activation in patients with sleep apnea","volume":"33","author":"von K\u00e4nel","year":"2005","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0160","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1172\/JCI119337","article-title":"Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation","volume":"99","author":"Lawson","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0165","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10059-010-0067-2","article-title":"HIF-1 and HIF-2 transcription factors\u2014similar but not identical","volume":"29","author":"Loboda","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2016.01.017_bb0170","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1101\/gad.11.1.72","article-title":"Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells","volume":"11","author":"Tian","year":"1997","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0175","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1182\/blood.V92.7.2260","article-title":"Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1\u03b1","volume":"92","author":"Wiesener","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbadis.2016.01.017_bb0180","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1101\/gad.1399906","article-title":"HIF-2alpha regulates oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth","volume":"20","author":"Covello","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0185","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1128\/MCB.25.13.5675-5686.2005","article-title":"Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel\u2013Lindau-associated renal cell carcinoma","volume":"25","author":"Raval","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0190","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/ham.2010.1099","article-title":"Hypoxia: adapting to high altitude by mutating EPAS-1, the gene encoding HIF-2alpha","volume":"12","author":"van Patot","year":"2011","journal-title":"High Alt. Med. Biol."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0195","article-title":"The OSBREAC Study Group, effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer","author":"Cui","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0200","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0021-9150(99)00063-5","article-title":"Tissue factor in atherosclerosis","volume":"144","author":"Tremoli","year":"1999","journal-title":"Atherosclerosis"},{"issue":"Supplement 2","key":"10.1016\/j.bbadis.2016.01.017_bb0205","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.thromres.2012.02.028","article-title":"Tissue factor-driven thrombin generation and inflammation in atherosclerosis","volume":"129","author":"ten Cate","year":"2012","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0210","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1161\/01.ATV.20.5.1362","article-title":"Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels","volume":"20","author":"Crawley","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0215","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1161\/01.RES.83.12.1264","article-title":"Expression of tissue factor pathway inhibitor in vascular smooth muscle cells and its regulation by growth factors","volume":"83","author":"Caplice","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2016.01.017_bb0220","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/(SICI)1096-9896(199906)188:2<180::AID-PATH338>3.0.CO;2-Q","article-title":"Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis","volume":"188","author":"Kaikita","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0225","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1161\/01.STR.32.4.850","article-title":"Expression of tissue factor in high-grade carotid artery stenosis: association with plaque destabilization","volume":"32","author":"Jander","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.bbadis.2016.01.017_bb0230","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/cvr\/cvt112","article-title":"Factor-Xa-induced mitogenesis and migration require sphingosine kinase activity and S1P formation in human vascular smooth muscle cells","volume":"99","author":"B\u00f6hm","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbadis.2016.01.017_bb0235","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1172\/JCI116031","article-title":"Thrombin receptor expression in normal and atherosclerotic human arteries","volume":"90","author":"Nelken","year":"1992","journal-title":"J. Clin. Invest."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443916300047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443916300047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T16:29:56Z","timestamp":1692203396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443916300047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0925443916300047"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2016.01.017","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EPAS1\/HIF-2 alpha-mediated downregulation of tissue factor pathway inhibitor leads to a pro-thrombotic potential in endothelial cells","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2016.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}